Hawkins Inc (HWKN) stock
HWKNNasdaqWholesale-Chemicals & Allied ProductsFiscal year ends March 28
Financials through Q2 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 26, 2026Score 14/3062% above fair value
$148.50−0.16 (-0.11%)
Close on Nov 17, 2026Market cap $3.09BP/E 36.0Yield 0.51%
Hawkins r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Hawkins
Hawkins has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?